Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Investing.com -- Ecolab reported second-quarter earnings slightly below Wall Street expectations, while revenue came in line with estimates, with company saying it saw strong performance in Life Sciences and its digital business.
The company reiterated its full-year profit guidance, which was in-line with consensus too.
Shares were trading flat at $270 before the opening bell.
Adjusted earnings per share were $1.89, a cent below the $1.90 consensus.
Revenue was $4.02 billion, matching consensus.
Ecolab (NYSE:ECL) Life Sciences provides cleaning and advanced contamination control expertise to pharmaceutical and personal care manufacturers.
The cleaning and hygiene products company maintained its 2025 adjusted EPS outlook of $7.42 to $7.62, compared with analysts’ average estimate of $7.52.
For the third quarter, Ecolab expects EPS of $2.02 to $2.12, bracketing the $2.07 consensus.
Margin gains were driven by pricing and SG&A leverage.
“While the macroeconomic environment remains unpredictable, we are confident in our growth drivers and our ability to execute,” said CEO Christophe Beck